- Home
- PMEC vs SER Comparison
PMEC vs SER Comparison
Compare PMEC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- SER
- Stock Information
- Founded
- PMEC 1984
- SER 2017
- Country
- PMEC Singapore
- SER United States
- Employees
- PMEC N/A
- SER N/A
- Industry
- PMEC
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- SER Health Care
- Exchange
- PMEC Nasdaq
- SER Nasdaq
- Market Cap
- PMEC 56.9M
- SER 55.2M
- IPO Year
- PMEC 2023
- SER 2018
- Fundamental
- Price
- PMEC $1.60
- SER $5.00
- Analyst Decision
- PMEC
- SER Strong Buy
- Analyst Count
- PMEC 0
- SER 2
- Target Price
- PMEC N/A
- SER $13.00
- AVG Volume (30 Days)
- PMEC 137.8K
- SER 43.2K
- Earning Date
- PMEC 01-01-0001
- SER 11-11-2025
- Dividend Yield
- PMEC N/A
- SER N/A
- EPS Growth
- PMEC N/A
- SER N/A
- EPS
- PMEC N/A
- SER N/A
- Revenue
- PMEC $74,349,000.00
- SER $130,000.00
- Revenue This Year
- PMEC N/A
- SER $134.46
- Revenue Next Year
- PMEC N/A
- SER N/A
- P/E Ratio
- PMEC N/A
- SER N/A
- Revenue Growth
- PMEC 2.52
- SER N/A
- 52 Week Low
- PMEC $0.54
- SER $3.81
- 52 Week High
- PMEC $2.44
- SER $7.92
- Technical
- Relative Strength Index (RSI)
- PMEC 37.62
- SER 48.12
- Support Level
- PMEC $1.58
- SER $4.60
- Resistance Level
- PMEC $2.30
- SER $5.01
- Average True Range (ATR)
- PMEC 0.21
- SER 0.24
- MACD
- PMEC -0.05
- SER -0.02
- Stochastic Oscillator
- PMEC 2.51
- SER 57.97
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.